Rare Neurogenetic Disorders Affect Millions of Lives
Neurogenetic disorders are caused by inherited or acquired genetic abnormalities that affect the brain, spinal cord, peripheral nerves, or neuromuscular systems. Many of these conditions are progressive, difficult to treat, and associated with significant unmet medical need. Because the nervous system is protected by complex biological barriers, delivering therapeutics to the affected tissues remains one of the major challenges in neurological medicine.
Delivery Remains a Major Bottleneck in Neurology
For RNA and genetic therapeutics to achieve meaningful biological activity, therapeutic payloads must reach the appropriate cells within the central nervous system while minimizing unnecessary exposure to other organs. AlterRNA is evaluating investigational targeted delivery concepts designed to improve transport toward disease-relevant neurological tissues after systemic administration.
Current Neurogenetic Research Areas
AlterRNA is exploring RNA therapeutic concepts and delivery strategies for rare neurological and neurodegenerative disorders where effective treatment options remain limited.
NBIA / MPAN
Investigational RNA therapeutic and gene-editing research focused on neurodegeneration with brain iron accumulation disorders.
Brain Targeted Delivery
Evaluating targeted delivery approaches designed to improve central nervous system accumulation.
RNA Rescue Strategies
Exploring investigational approaches intended to support cellular function and minimize neurological damage.
Precision Genetic Medicine
Research focused on mutation-specific therapeutic concepts for rare neurological diseases.
Combining RNA Therapeutics and Delivery Research
Our investigational approach combines RNA therapeutic design, molecular engineering, and targeted delivery research to evaluate strategies that may support future neurogenetic therapeutic development.
This work remains investigational and is not an approved treatment.
FUTURE DIRECTIONS
Advancing Research for Rare Neurological Diseases
AlterRNA aims to continue expanding research into targeted delivery systems, RNA therapeutic technologies, and translational approaches relevant to neurogenetic disorders and central nervous system diseases.
Explore Our Neurology Research
Learn more about AlterRNA’s investigational research platform focused on neurogenetic disease, targeted delivery, and RNA therapeutics.